André Archambault

1.9k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

André Archambault is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, André Archambault has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 5 papers in Gastroenterology and 4 papers in Epidemiology. Recurrent topics in André Archambault's work include Helicobacter pylori-related gastroenterology studies (7 papers), Gastroesophageal reflux and treatments (4 papers) and Microscopic Colitis (4 papers). André Archambault is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (7 papers), Gastroesophageal reflux and treatments (4 papers) and Microscopic Colitis (4 papers). André Archambault collaborates with scholars based in Canada, United States and United Kingdom. André Archambault's co-authors include Douglas G. Kinnear, James Rochon, Richard N. Fedorak, E. Jan Irvine, Brian G. Feagan, Aubrey Groll, John WD McDonald, William J. Sandborn, Richard Gillies and Fred Saibil and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

André Archambault

14 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease

1994 581 citations E. Jan Irvine, Brian G. Feagan et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Archambault Canada	11	906	741	548	242	169	14	1.5k
Douglas G. Kinnear Canada	9	660 0.7×	664 0.9×	695 1.3×	422 1.7×	102 0.6×	9	1.5k
Jason M. Swoger United States	26	962 1.1×	856 1.2×	578 1.1×	317 1.3×	142 0.8×	71	1.6k
Véred Abitbol France	24	876 1.0×	727 1.0×	413 0.8×	138 0.6×	280 1.7×	66	1.7k
Arthur Barrie United States	24	961 1.1×	813 1.1×	454 0.8×	156 0.6×	253 1.5×	84	1.6k
Marc Schwartz United States	23	1.0k 1.1×	853 1.2×	459 0.8×	196 0.8×	153 0.9×	76	1.5k
Jan E. Irvine Canada	6	1.1k 1.3×	877 1.2×	517 0.9×	229 0.9×	187 1.1×	9	1.4k
Marte Lie Høivik Norway	21	1.0k 1.1×	1.0k 1.4×	435 0.8×	157 0.6×	267 1.6×	63	1.8k
Maurice G. Rüssel Netherlands	22	1.3k 1.4×	1.0k 1.4×	632 1.2×	108 0.4×	127 0.8×	52	1.7k
D. H. Present United States	6	1.4k 1.6×	1.1k 1.5×	505 0.9×	107 0.4×	236 1.4×	11	1.7k
Leonard Baidoo United States	21	1.7k 1.9×	1.4k 2.0×	629 1.1×	169 0.7×	277 1.6×	77	2.0k

Countries citing papers authored by André Archambault

Since Specialization

Citations

This map shows the geographic impact of André Archambault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Archambault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Archambault more than expected).

Fields of papers citing papers by André Archambault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Archambault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Archambault. The network helps show where André Archambault may publish in the future.

Co-authorship network of co-authors of André Archambault

This figure shows the co-authorship network connecting the top 25 collaborators of André Archambault. A scholar is included among the top collaborators of André Archambault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Archambault. André Archambault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hanauer, Stephen B., et al.. (2007). Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial. SHILAP Revista de lepidopterología. 21(12). 827–834. 111 indexed citations

Sandborn, William J., Brian G. Feagan, S. B. Hanauer, et al.. (2001). An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial. Gastroenterology. 120(6). 1330–1338. 197 indexed citations

Lahaie, Raymond, Alain Farley, Chrystian Dallaire, et al.. (2001). Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication ofHelicobacter pylori. SHILAP Revista de lepidopterología. 15(9). 581–585. 21 indexed citations

Zanten, Sander Veldhuyzen van, Alain Farley, Norman E. Marcon, et al.. (2000). Bismuth-Based Triple Therapy with Bismuth Subcitrate, Metronidazole and Tetracycline in the Eradication ofHelicobacter pylori: A Randomised, Placebo Controlled, Double-Blind Study. SHILAP Revista de lepidopterología. 14(7). 599–602. 14 indexed citations

Archambault, André, et al.. (1996). Comparison of Omeprazole with Ranitidine for Treatment of Symptoms Associated with Gastroesophageal Reflux Disease and Uncomplicated Duodenal Ulcer. SHILAP Revista de lepidopterología. 10(3). 156–162. 1 indexed citations

Irvine, E. Jan, Brian G. Feagan, James Rochon, et al.. (1994). Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 106(2). 287–296. 581 indexed citations breakdown →

Feagan, Brian G., John WD McDonald, James Rochon, et al.. (1994). Low-Dose Cyclosporine for the Treatment of Crohn's Disease. New England Journal of Medicine. 330(26). 1846–1851. 196 indexed citations

Grégoire, Jean‐Pierre, R Guibert, André Archambault, & André‐Pierre Contandriopoulos. (1992). Medication Compliance in a Family Practice: Testimg a self-report questionnaire in a primary care setting.. PubMed. 38. 2333–7. 16 indexed citations

Archambault, André, Pierre Paré, R.J. Bailey, et al.. (1988). Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology. 94(5). 1130–1134. 59 indexed citations

10.

Archambault, André, Alain Farley, I. G. M. Cleator, et al.. (1985). Cimetidine therapy for gastroesophageal reflux disease.. PubMed. 143(5). 616–21. 7 indexed citations

11.

Sontag, Stephen J., David Y. Graham, Alphonso Belsito, et al.. (1984). Cimetidine, Cigarette Smoking, and Recurrence of Duodenal Ulcer. New England Journal of Medicine. 311(11). 689–693. 169 indexed citations

12.

Gougeon, F., et al.. (1976). Pancreatic trauma: A new diagnostic approach. The American Journal of Surgery. 132(3). 400–402. 30 indexed citations

13.

Archambault, André. (1967). Pharmaceutical Education—A Dual Challenge. 1(7). 228–230. 1 indexed citations

14.

Archambault, André, Randolph A. Rovelstad, & Harley C. Carlson. (1967). In Situ ph of Duodenal Bulb Contents in Normal and Duodenal Ulcer Subjects. Gastroenterology. 52(6). 940–947. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact